Conglomerate Effects: An EU Resurgence?

Our success is built on our clients’ success. We have a long and distinguished history of supporting our clients wherever they do business, from major financial centers to emerging and growth markets. We represent many of the world’s leading corporations and major financial institutions, as well as emerging growth companies, governments and state-owned enterprises, often working on ground-breaking, precedent-setting matters. With a deep understanding of our clients' businesses and the industries they operate in, our work is driven by their need for outstanding legal and commercial advice.

Explore

The European Commission (EC) is increasingly invoking conglomerate theories of harm in its merger reviews.

European Union Antitrust/Competition Law

Authors

To print this article, all you need is to be registered or login on Mondaq.com.

The European Commission (EC) is increasingly invoking conglomerate theories of harm in its merger reviews. The complexity of these theories is resulting in more in-depth Phase 2 reviews and behavioral access commitments are relatively common for conglomerate mergers in the high-tech space.

Read this chapter in Shearman & Sterling's 2019 Antitrust Annual Report, "Conglomerate Effects: An EU Resurgence?"

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Authors

Matthew Readings